Clinical TrialsSearch results
Number of results: 818
Other
- A study for the effect of ulinastatin for suppression of hyperamylasemia and hyperlipasemia induced by peroral double-balloon enteroscopy
- Patients who undergo peroral double-balloon enteroscopy
- Intmed3 DBE study group
- 2007-10-01
Other
- A study in healthy men to test how well different doses of BI 1819479 are tolerated
- Idiopathic pulmonary fibrosis,Interstitial lung diseases with progressive phenotype,Systemic scleros
- Suzuki Haruka
- 2022-07-14
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- A STUDY OF FARICIMAB WITH ANGIOID STREAKS.
- Angioid Streaks
- Iida Tomohiro
- 2023-01-18
Other
- A Study of LY3209590 Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
- Type 1 Diabetes Diabetes
- Masaki Takeshi
- 2022-08-19
Other
- A Study of LY3526318 in Healthy Male Japanese Participants
- Healthy
- Wakayama Naohiko
- 2022-11-25
Other
- A study on measurement of KP-103 concentration in nails (Phase I) - Investigation of KP-103 concentration in nails following repeated topical application to toenails in patients with onychomycosis -
- Onychomycosis
- KAKEN PHARMACEUTICAL CO.,LTD.
- 2009-05-08
Other
- A study on the long-term efficacy, safety and persistence of immune response of a vaccine against Herpes Zoster in older adults
- Herpes zoster (Shingles) disease.
- Okawa Yasutoshi
- 2022-08-05
Other
- A Study to Compare the Efficacy and Safety of Oral Azacitidine (Oral-Aza, ONUREG) plus BSC versus Placebo plus BSC in Participants with IPSS-R Low- or Intermediate-risk MDS
- Myelodysplastic Syndrome
- Carlos Vigil
- 2023-01-18
Other
- A study to investigate safety, tolerability, and pharmacokinetics of AZD7503 in healthy Japanese participants.
- nonalcoholic fatty liver disease
- Ageishi Yuji
- 2023-10-17